Tutorials › Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling › Deriving Exposure-Driven Adaptation Dynamics

Tolerance, Rebound and Adaptation · Tutorial 187 of 598

Deriving Exposure-Driven Adaptation Dynamics

Learn to derive and calculate exposure-driven adaptation over constant, changing, and periodic concentration profiles, and connect the state to a simple pharmacodynamic response.

Advanced 11 min read

What You'll Learn

  • State the assumptions and units for a first-order exposure-driven adaptation model.
  • Derive its transient solution and steady state under constant concentration.
  • Calculate adaptation when concentration changes in steps.
  • Find the periodic adaptation levels under repeated on/off exposure.
  • Translate an adaptation state into a response using an explicit illustrative model.
  • Recognize when the model's positivity, stability, or mechanistic assumptions are not justified.

Why Exposure-Driven Adaptation Needs Its Own Time Course

A drug concentration can change much faster than a biological system adapts to it. Consequently, the same concentration may be associated with different responses depending on how long exposure has lasted and what the preceding concentration history was. A useful starting model treats adaptation as a state that is formed in response to concentration and removed by first-order recovery. Its central feature is memory: the current state depends on earlier exposure, with recent exposure weighted more heavily than distant exposure.

This tutorial derives the state trajectory and its steady state, then works through constant, changing, and repeated on/off concentrations. The model is deliberately compact. It describes an adaptation state driven directly by concentration; it does not establish which biological mechanism generated that state. When the state is linked to response, the particular response equation must also be stated.

Definition: Let \(C(t)\) be drug concentration and \(A(t)\) an adaptation state. The exposure-driven, first-order adaptation model is
$$ \frac{dA(t)}{dt}=k_{\mathrm{form}}C(t)-k_{\mathrm{rec}}A(t). $$
Here \(k_{\mathrm{form}}\geq 0\) is the formation coefficient, and \(k_{\mathrm{rec}}>0\) is the recovery rate constant. If \(A\) is dimensionless and \(C\) is measured in mg/L, then \(k_{\mathrm{form}}\) has units L/(mg·time), while \(k_{\mathrm{rec}}\) has units \(1/\text{time}\). The state \(A\) is not itself a concentration.

The first term increases adaptation in proportion to concentration; the second returns it toward zero. This linear specification assumes that formation is not saturated, recovery is proportional to the current state, and the parameters remain constant over the modeled period. Concentration is treated as a known input, or as an input supplied by a pharmacokinetic model. Those assumptions are modeling choices, not consequences of the equation.

Solution for Constant and Changing Concentrations

For a constant concentration \(C(t)=C_0\), the steady state is found by setting the derivative to zero. Since \(k_{\mathrm{rec}}>0\), there is a unique equilibrium. To derive the trajectory from an initial state \(A(0)=A_0\), subtract the equilibrium from both sides of the differential equation. The deviation then decays exponentially:

$$ A_{\mathrm{ss}}=\frac{k_{\mathrm{form}}}{k_{\mathrm{rec}}}C_0, \qquad \frac{d}{dt}\left(A-A_{\mathrm{ss}}\right) =-k_{\mathrm{rec}}\left(A-A_{\mathrm{ss}}\right), $$
$$ A(t)=A_{\mathrm{ss}}+(A_0-A_{\mathrm{ss}})e^{-k_{\mathrm{rec}}t}. $$

The exponential factor shows that the difference from steady state is multiplied by \(e^{-1}\) after \(1/k_{\mathrm{rec}}\) time units. Thus the adaptation time constant is \(1/k_{\mathrm{rec}}\), and its half-time is \(\ln(2)/k_{\mathrm{rec}}\). A time constant is not the time required to reach steady state exactly: the exponential approach is asymptotic.

Worked Example: Adaptation During Constant Exposure

Suppose, hypothetically, that concentration is held at \(3\) mg/L, \(k_{\mathrm{form}}=0.04\) L/(mg·day), \(k_{\mathrm{rec}}=0.20\) day\(^{-1}\), and \(A_0=0.10\). Calculate adaptation after 5 days and its steady state.

The steady state and transient solution are

$$ A_{\mathrm{ss}}=\frac{0.04\ \mathrm{L/(mg\cdot day)}}{0.20\ \mathrm{day}^{-1}} (3\ \mathrm{mg/L})=0.60, $$
$$ A(5)=0.60+(0.10-0.60)e^{-(0.20)(5)} =0.60-0.50e^{-1}=0.4161. $$

The state is 0.4161 after 5 days and approaches 0.60 with continued constant exposure. The time constant is \(1/0.20=5.00\) days; at that time, the remaining gap to steady state is \(e^{-1}\) of its initial value.

For a changing concentration, the integrating-factor method gives a solution that makes the memory explicit. Multiply the differential equation by \(e^{k_{\mathrm{rec}}t}\), integrate from 0 to \(t\), and divide by \(e^{k_{\mathrm{rec}}t}\):

$$ \frac{d}{dt}\left(e^{k_{\mathrm{rec}}t}A(t)\right) =k_{\mathrm{form}}e^{k_{\mathrm{rec}}t}C(t), $$
$$ A(t)=A_0e^{-k_{\mathrm{rec}}t} +k_{\mathrm{form}}\int_0^t e^{-k_{\mathrm{rec}}(t-s)}C(s)\,ds. $$

This is a complete solution for any integrable concentration history under the stated model. Each earlier concentration \(C(s)\) contributes in proportion to \(e^{-k_{\mathrm{rec}}(t-s)}\), so its contribution fades as time passes. If \(C(t)\geq 0\), \(A_0\geq 0\), and \(k_{\mathrm{form}}\geq 0\), both terms in the solution are nonnegative, and therefore \(A(t)\geq 0\). This conclusion depends on the nonnegative formation-coefficient assumption.

Worked Example: A Step Increase in Concentration

In a hypothetical case, concentration is \(2\) mg/L for the first 4 days and then increases to \(5\) mg/L for 3 more days. Let \(A_0=0\), \(k_{\mathrm{form}}=0.05\) L/(mg·day), and \(k_{\mathrm{rec}}=0.25\) day\(^{-1}\). Find \(A\) at days 4 and 7.

During the first interval, the constant-input equilibrium is \(A_{\mathrm{ss},1}=(0.05/0.25)(2)=0.40\). Therefore,

$$ A(4)=0.40+(0-0.40)e^{-(0.25)(4)} =0.40(1-e^{-1})=0.2528. $$

At day 4, the concentration changes, but the state does not jump: \(A(4)=0.2528\) is the initial state for the second interval. The new equilibrium is \(A_{\mathrm{ss},2}=(0.05/0.25)(5)=1.00\), so 3 days later,

$$ A(7)=1.00+(0.2528-1.00)e^{-(0.25)(3)} =1.00-0.7472e^{-0.75}=0.6471. $$

The state rises toward 1.00 after the increase in concentration, but remains below that equilibrium at day 7. Using the first interval's equilibrium throughout would ignore the changed input; resetting \(A\) to zero at day 4 would incorrectly erase adaptation already formed.

Repeated On/Off Exposure and Periodic Steady State

A repeated schedule can produce a periodic adaptation state even when concentration switches abruptly between two levels. Let concentration equal \(C_{\max}\) for \(\tau_{\mathrm{on}}\), then zero for \(\tau_{\mathrm{off}}\), repeating with the same durations. Define \(A_{\min}\) as the state just before an on-period and \(A_{\max}\) as the state at its end. During the on-period, the constant-input equilibrium is \(A_{\mathrm{ss}}=k_{\mathrm{form}}C_{\max}/k_{\mathrm{rec}}\); during the off-period, the equilibrium is zero. With \(q=e^{-k_{\mathrm{rec}}\tau_{\mathrm{on}}}\) and \(r=e^{-k_{\mathrm{rec}}\tau_{\mathrm{off}}}\), the state updates are

$$ A_{\max}=A_{\mathrm{ss}}+(A_{\min}-A_{\mathrm{ss}})q, \qquad A_{\min,\mathrm{next}}=rA_{\max}. $$

At periodic steady state, \(A_{\min,\mathrm{next}}=A_{\min}\). Substituting the first update into the second yields \(A_{\min}=r[A_{\mathrm{ss}}(1-q)+qA_{\min}]\). Rearranging gives \(A_{\min}(1-rq)=rA_{\mathrm{ss}}(1-q)\). Because \(0<r,q<1\), \(1-rq>0\), so the periodic levels are uniquely determined:

$$ A_{\min}=\frac{r(1-q)}{1-rq}A_{\mathrm{ss}}, \qquad A_{\max}=\frac{1-q}{1-rq}A_{\mathrm{ss}}. $$

Worked Example: Periodic Adaptation Under One-Day On/Off Exposure

Consider a hypothetical repeating schedule with concentration \(4\) mg/L for 1 day and zero for 1 day. Let \(k_{\mathrm{form}}=0.03\) L/(mg·day) and \(k_{\mathrm{rec}}=0.20\) day\(^{-1}\). Calculate the periodic minimum and maximum adaptation states.

The on-period equilibrium is \(A_{\mathrm{ss}}=(0.03/0.20)(4)=0.600\). Since each interval lasts 1 day, \(q=r=e^{-0.20}=0.8187\), and \(1-rq=1-e^{-0.40}=0.3297\). Thus,

$$ A_{\max}=\frac{1-0.8187}{0.3297}(0.600)=0.3299, \qquad A_{\min}=0.8187(0.3299)=0.2701. $$

At periodic steady state, adaptation varies from approximately 0.2701 before exposure to 0.3299 at the end of exposure. It does not return to zero between these daily exposures because recovery during the one-day off-period is incomplete.

Connecting the State to Response

The adaptation equation alone predicts \(A(t)\), not a clinical or biomarker response. To calculate a response consequence, specify how the state enters the pharmacodynamic observation model. For illustration, suppose the drug's response in the absence of adaptation is \(E_{\max}C/(EC_{50}+C)\), and adaptation opposes that response additively:

$$ Y(t)=\frac{E_{\max}C(t)}{EC_{50}+C(t)}-\gamma A(t). $$

Here \(Y\) is the drug-related response relative to baseline, \(E_{\max}\) and \(Y\) share response units, \(EC_{50}\) has concentration units, and \(\gamma\) has response units per unit of \(A\). This is one illustrative link, not a universal consequence of exposure-driven adaptation. It assumes an additive opposing effect and may be inappropriate if the response is constrained to a range that the equation can exceed.

Worked Example: Response Change as Adaptation Accumulates

Use the constant-exposure example with \(C=3\) mg/L and \(A(5)=0.4161\). Suppose, hypothetically, \(E_{\max}=80\) response units, \(EC_{50}=1.5\) mg/L, and \(\gamma=30\) response units per unit of adaptation. Calculate the response at day 0 and day 5, assuming \(A(0)=0.10\).

The concentration-dependent component is constant:

$$ \frac{E_{\max}C}{EC_{50}+C} =\frac{(80)(3)}{1.5+3}=53.33\ \text{response units}. $$

At day 0, \(Y(0)=53.33-(30)(0.10)=50.33\) response units. At day 5, \(Y(5)=53.33-(30)(0.4161)=40.85\) response units. Under this specified equation, the response is lower after 5 days because the opposing adaptation state has increased. This calculation does not by itself identify the biological mechanism or establish that the same response link applies in another setting.

Assumptions, Diagnostics, and Alternatives

The model has stable, interpretable behavior when \(k_{\mathrm{rec}}>0\). If \(k_{\mathrm{rec}}=0\), \(k_{\mathrm{form}}>0\), and concentration is constant and positive, then \(A\) increases linearly and does not approach a finite steady state. If \(k_{\mathrm{form}}=0\) as well, \(A\) remains constant. If \(k_{\mathrm{rec}}<0\), the recovery term instead drives the state away from zero, so the model is unstable. For a nonnegative state under nonnegative exposure, also require \(k_{\mathrm{form}}\geq0\), \(C(t)\geq0\), and \(A_0\geq0\). If \(k_{\mathrm{form}}<0\), the input term can drive the state negative even from \(A_0=0\).

In data, warning signs include systematic response residuals that vary with time on treatment, different observed trajectories after rising and falling concentrations when the model predicts otherwise, or adaptation estimates that require biologically implausible parameter signs. The assumed direct proportionality to concentration can also fail if formation saturates or depends on another mediator. A fitted state trajectory is not proof that the state is a real biological quantity; its interpretation depends on the model and evidence.

Alternatives answer different mechanistic questions. A direct concentration-response model has no adaptation memory. An effect-compartment model represents delayed equilibration between plasma concentration and a response site; it should not automatically be interpreted as tolerance. Turnover and explicit feedback models represent production, loss, or regulated mediators in more mechanistic detail, at the cost of additional parameters and assumptions. The first-order exposure-driven state is useful when a compact representation of delayed adaptation is adequate, but it cannot distinguish among mechanisms that produce similar time courses.

Common pitfall: “At \(A=0\), the state cannot become negative because recovery is zero.” That reasoning ignores the formation term: the derivative at zero is \(k_{\mathrm{form}}C(t)\). Nonnegativity follows when \(k_{\mathrm{form}}\geq0\), \(C(t)\geq0\), \(A_0\geq0\), and \(k_{\mathrm{rec}}>0\), as is also clear from the integral solution. A negative formation coefficient can make the state decrease below zero.

Check Your Understanding

Try each question, then compare your work with the brief solutions below.

  1. For constant \(C_0=2\) mg/L, \(k_{\mathrm{form}}=0.06\) L/(mg·day), and \(k_{\mathrm{rec}}=0.30\) day\(^{-1}\), what is the steady state?
  2. With those parameters and \(A_0=0\), what is \(A(2)\)?
  3. State the conditions that ensure nonnegative adaptation when concentration is nonnegative.
  4. In a periodic on/off schedule, why is the minimum adaptation generally above zero when the off-period is finite?

Solutions. (1) \(A_{\mathrm{ss}}=(0.06/0.30)(2)=0.400\). (2) \(A(2)=0.400+(0-0.400)e^{-0.60}=0.1805\). (3) Require \(A_0\geq0\), \(C(t)\geq0\), \(k_{\mathrm{form}}\geq0\), and \(k_{\mathrm{rec}}>0\); then the initial-state term and the integral in the solution are both nonnegative. (4) During the finite off-period, \(A\) is multiplied by \(e^{-k_{\mathrm{rec}}\tau_{\mathrm{off}}}\), which is positive for finite \(\tau_{\mathrm{off}}\). Thus some state remains to carry into the next on-period at periodic steady state.

Clinical Biostats